Prevalence and predictors of critical COVID-19 pneumonia among patients with COVID-19 admitted at Nyarugenge major COVID-19 Referral Center in Rwanda
Open Access
- 24 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1639
Abstract
Coronavirus Disease 2019(COVID-19) pneumonia, caused by the Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2 virus), remains a significant global health challenge, contributing to millions of cases and deaths worldwide, including a substantial burden in Rwanda. Severe and critical cases often lead to respiratory failure, multi-organ dysfunction, and increased mortality. Despite global research, data on predictors of critical illness among hospitalized COVID-19 patients in Rwanda remain limited, highlighting the need for context-specific studies. This study aimed to assess the prevalence and identify risk factors for critical COVID-19 pneumonia among patients admitted to the Nyarugenge Major COVID-19 Referral Center in Rwanda. A mixed-study design combining retrospective and prospective designs was conducted from February to October 2021, and we included 320 patients aged 15 to 65 years admitted with severe or critical COVID-19 pneumonia. Data were collected on socio-demographic factors, vital signs, and clinical symptoms. Multivariate logistic regression was performed using Stata 17 to identify independent predictors of critical illness. Of the 320 patients, 30% presented with critical illness, while 70% had severe illness. Independent predictors of critical illness included oxygen saturation ≤ 90% {Adjusted Odds Ratio (AOR) = 5.83, 95% Confidence Interval(CI): 2.95–11.52, p < 0.001), respiratory rate > 20 beat per minute(bpm), (AOR = 2.34, 95% CI: 1.11–4.93, p < 0.05), and heart rate > 100 bpm (AOR = 2.49, 95% CI: 1.32–4.67, p < 0.01). Critical illness was prevalent in 30% of patients, with hypoxia, tachypnea, and tachycardia as significant predictors. These findings identify key clinical predictors of critical COVID-19 pneumonia and suggest that monitoring these indicators may help guide early intervention and optimize resource allocation in Rwanda and similar low- and middle-income settings. Not applicable.Keywords
This publication has 41 references indexed in Scilit:
- Validation of oxygen saturations measured in the community by emergency medical services as a marker of clinical deterioration in patients with confirmed COVID-19: a retrospective cohort studyBMJ Open, 2024
- Research from low-income and middle-income countries will benefit global health and the physiotherapy profession, but it requires supportJournal of Manual & Manipulative Therapy, 2023
- Pathophysiology of Hypoxemia in COVID-19 Lung DiseaseClinics in Chest Medicine, 2022
- Silent hypoxia is not an identifiable characteristic in patients with COVID-19 infectionRespiratory Medicine, 2022
- Risk and Protective Factors for COVID-19 Morbidity, Severity, and MortalityClinical Reviews in Allergy & Immunology, 2022
- Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort studyThe Lancet, 2021
- Predictive indicators of severe COVID-19 independent of comorbidities and advanced age: a nested case−control studyEpidemiology and Infection, 2020
- COVID-19: pathophysiology, diagnosis, complications and investigational therapeuticsNew Microbes and New Infections, 2020
- Risk factors for the COVID‐19 severity and its correlation with viral shedding: A retrospective cohort studyJournal of Medical Virology, 2020
- A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2The FEBS Journal, 2020